|
YTHDF3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.08189998573971E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.42739999989361E-07 |
| Normal-vs-Stage2 |
2.43939999999832E-05 |
| Normal-vs-Stage3 |
3.80300002600364E-09 |
| Normal-vs-Stage4 |
5.82369996671162E-09 |
| Stage1-vs-Stage2 |
6.052600E-01 |
| Stage1-vs-Stage3 |
9.747600E-02 |
| Stage1-vs-Stage4 |
2.954200E-02 |
| Stage2-vs-Stage3 |
5.104600E-01 |
| Stage2-vs-Stage4 |
1.791410E-01 |
| Stage3-vs-Stage4 |
3.614600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.52529996913609E-09 |
| Normal-vs-AfricanAmerican |
7.475800E-03 |
| Normal-vs-Asian |
2.5890000000528E-06 |
| Caucasian-vs-AfricanAmerican |
3.631200E-01 |
| Caucasian-vs-Asian |
7.860600E-01 |
| AfricanAmerican-vs-Asian |
3.392800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.2729999998573E-07 |
| Normal-vs-Female |
5.26610000051164E-09 |
| Male-vs-Female |
7.577800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.74897999999368E-05 |
| Normal-vs-Age(41-60Yrs) |
3.03539970936129E-10 |
| Normal-vs-Age(61-80Yrs) |
6.59809999969951E-08 |
| Normal-vs-Age(81-100Yrs) |
4.346100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.108500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.623780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.684000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.723400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.714400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.084800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.746100E-02 |
| Classical-VS-Follicular |
4.912300E-02 |
| Classical-VS-Other |
2.247200E-01 |
| Classical-VS-Normal |
5.59089999963014E-07 |
| Tall-VS-Follicular |
5.259600E-01 |
| Tall-VS-Other |
8.249600E-01 |
| Tall-VS-Normal |
8.65670000016472E-07 |
| Follicular-VS-Other |
5.954400E-01 |
| Follicular-VS-Normal |
8.7430000017541E-08 |
| Other-VS-Normal |
3.262300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.49059994850143E-09 |
| Normal-vs-N1 |
9.10909999651821E-08 |
| N0-vs-N1 |
5.273400E-01 |
|
|
